Seaport Therapeutics
SPTX19.9003.12% ( -0.640 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Seaport Therapeutics(SPTX) predict that the EBIT is -27.54 M (--%), Beat estimate;the EPS is -10.34 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.03B--
-0.03B--
+0.00B--%
EPSMiss expectations
-10.34--
-8.17--
-2.1700--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf